EUVIMEDEUVIMED entdecken
Open Access · CC0

SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes

Pandora L Wander iD, Elliott Lowy, Anna Korpak, Lauren A Beste iD, Steven E Kahn iD, Edward J Boyko

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0317348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Pandora L Wander und 5 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington, United States of America. Hauptthemen laut MEDLINE: COVID-19, Veterans, Diabetes Mellitus. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: VAPSHCS Office of Research & Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the impact of SARS-CoV-2 on long-term glycemia. Research design and methods We conducted a retrospective inception cohort study using Veterans Health Administration data (March 1, 2020–May 31, 2022) among individuals with ≥ 1 positive nasal swab for SARS-CoV-2 and individuals with ≥ 1 laboratory test of any type but no positive swab. Two incident diabetes cohorts were defined based on: 1) a computable phenotype using a combination of diagnosis codes, laboratory tests, and receipt of glucose-lowering medications (n = 17,754); and 2) the presence of ≥ 2 HbA1c results ≥ 6.5% (n = 4,768). We fit log-binomial models examining associations of SARS-CoV-2 with diabetes remission, defined as ≥ 2 HbA1c measurements < 6.5% ≥ 90 days apart after cessation of any glucose-lowering medications. To help equalize laboratory surveillance of glycemia, we conducted a subgroup analysis among non-hospitalized participants.

Results

In cohorts 1 and 2 respectively, 25% and 29% had ≥ 1 positive test for SARS-CoV-2 prior to enrollment, and 21% and 11% had remission. SARS-CoV-2 was associated with a higher chance of remission by both definitions (1: RR 1.22 [95%CI 1.14–1.29]; 2: RR 1.27 [95%CI 1.07–1.50]) over an average 503 (±202) and 494 (±184) days. The association was attenuated among non-hospitalized participants (1: RR 1.11 [1.04–1.20]; 2: R: 1.17 [95%CI 0.97–1.42]).

Conclusions

Diabetes remission was more common in Veterans with new-onset diabetes after SARS-CoV-2. In non-hospitalized participants, who were likely to have more similar laboratory surveillance, the association was diminished. Differences in surveillance or transient hyperglycemia may explain the observed association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19VeteransDiabetes MellitusHumansMaleFemaleMiddle AgedRetrospective StudiesAgedSARS-CoV-2United StatesGlycated HemoglobinRemission InductionIncidenceAdult

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington, United States of America.
  • Department of Medicine, University of Washington, Seattle, Washington, United States of America.

ORCID-Profile: Pandora L Wander, Lauren A Beste, Steven E Kahn

Förderung

  • VAPSHCS Office of Research & Development

Zitieren

APA

Wander, P. L., Lowy, E., Korpak, A., Beste, L. A., Kahn, S. E., & Boyko, E. J. (2025). SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes. PLOS ONE. https://doi.org/10.1371/journal.pone.0317348

Vancouver

Wander PL, Lowy E, Korpak A, Beste LA, Kahn SE, Boyko EJ. SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes. PLOS ONE. 2025. doi:10.1371/journal.pone.0317348

BibTeX
@article{Wander2025,
  author = {Wander, Pandora L and Lowy, Elliott and Korpak, Anna and Beste, Lauren A and Kahn, Steven E and Boyko, Edward J},
  title = {SARS-CoV-2 infection is associated with higher chance of diabetes remission among Veterans with incident diabetes},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0317348}
}
Kostenlos starten →